Mindfulness-based intervention for Depression

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Sunnybrook Health Sciences Centre, Toronto, Canada
Depression+3 More
Mindfulness-Based Intervention - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

Mindfulness-based interventions (MBIs) have emerged as clinically effective interventions for anxiety, depression, and general distress. However, there are significant barriers to accessing MBIs in the general population including length of treatment and cost. Furthermore, in the present COVID-19 pandemic, there is a demand to conduct virtual clinical services. However, to date, not much is known regarding the effectiveness of mindfulness groups that are conducted virtually. The aim of the present study is to examine the effectiveness of a five-week abbreviated MBCT intervention delivered virtually for a physician-referred, treatment-seeking, community sample. The virtual mindfulness group will be compared to a five-week wait-list control group. All wait-listed study participants will be given the opportunity to participate in the intervention after study completion. At present, clinical wait times for services far exceed five weeks, thus participants that are wait-listed will not experience delay in their treatment.

Eligible Conditions

  • Depression
  • Anxiety

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 5 Secondary · Reporting Duration: At three time points (weeks 0,3, and 5) over 5 week intervention period.

Week 5
Depression, Anxiety, Stress Scale-21 (DASS-21)
Five Facet Mindfulness Questionnaire (FFMQ)
Generalized Anxiety Disorder - 7 (GAD-7)
Maslach Burnout Inventory (MBI)
Patient Health Questionnaire - 9 (PHQ-9)
Perceived Stress Scale (PSS)
Self-Compassion Scale
Warwick Edinburgh Mental Well- Being Scale (WEMWBS)

Trial Safety

Trial Design

2 Treatment Groups

Waitlist
1 of 2
Mindfulness-based intervention
1 of 2
Active Control
Experimental Treatment

80 Total Participants · 2 Treatment Groups

Primary Treatment: Mindfulness-based intervention · No Placebo Group · N/A

Mindfulness-based intervention
Behavioral
Experimental Group · 1 Intervention: Mindfulness-Based Intervention · Intervention Types: Behavioral
WaitlistNoIntervention Group · 1 Intervention: Waitlist · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness-Based Intervention
2016
N/A
~50

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: at three time points (weeks 0,3, and 5) over 5 week intervention period.

Trial Background

Dr. Neil Rector, MD
Principal Investigator
Sunnybrook Health Sciences Centre
Closest Location: Sunnybrook Health Sciences Centre · Toronto, Canada
Photo of sunnybrook health sciences centre  1Photo of sunnybrook health sciences centre  2Photo of sunnybrook health sciences centre  3
2007First Recorded Clinical Trial
23 TrialsResearching Depression
422 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are 18 years of age or older.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.